DOP2017000238A - COMBINATION OF AT LEAST ONE PROTEASE INHIBITOR AND AT LEAST AN ACTIVE PRINCIPLE FOR USE IN THE PREVENTION AND / OR TREATMENT OF SKIN INJURY - Google Patents
COMBINATION OF AT LEAST ONE PROTEASE INHIBITOR AND AT LEAST AN ACTIVE PRINCIPLE FOR USE IN THE PREVENTION AND / OR TREATMENT OF SKIN INJURYInfo
- Publication number
- DOP2017000238A DOP2017000238A DO2017000238A DO2017000238A DOP2017000238A DO P2017000238 A DOP2017000238 A DO P2017000238A DO 2017000238 A DO2017000238 A DO 2017000238A DO 2017000238 A DO2017000238 A DO 2017000238A DO P2017000238 A DOP2017000238 A DO P2017000238A
- Authority
- DO
- Dominican Republic
- Prior art keywords
- prevention
- treatment
- combination
- protease inhibitor
- active principle
- Prior art date
Links
Abstract
La invención se refiere a una combinación que comprende al menos un inhibidor de proteasa, que puede ser diferentes orígenes, tal como plantas, frutas, salvado de arroz, semillas de frijol, soja o papa y al menos un principio activo adicional, seleccionado de óxido de zinc, dexpantenol, pantenol, cloruro de benzalconio, cetrimida, clotrimazol, nistatina, dimeticona, aloe vera, o caléndula y a su uso en la prevención y/o tratamiento de lesiones de piel causadas por orina y/o heces y como adyuvante en la reparación de piel. La invención además se refiere a dicha combinación en asociación con principios activos adicionales y a su uso en la prevención y/o tratamiento de lesiones de piel causadas por proteasas en las heces y como adyuvante en la reparación de piel.The invention relates to a combination comprising at least one protease inhibitor, which may be different origins, such as plants, fruits, rice bran, beans, soybeans or potatoes and at least one additional active ingredient, selected from oxide. of zinc, dexpanthenol, panthenol, benzalkonium chloride, cetrimide, clotrimazole, nystatin, dimethicone, aloe vera, or calendula and its use in the prevention and / or treatment of skin lesions caused by urine and / or feces and as an adjuvant in the skin repair The invention also relates to said combination in association with additional active ingredients and its use in the prevention and / or treatment of skin lesions caused by proteases in the feces and as an adjuvant in skin repair.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DO2017000238A DOP2017000238A (en) | 2017-10-16 | 2017-10-16 | COMBINATION OF AT LEAST ONE PROTEASE INHIBITOR AND AT LEAST AN ACTIVE PRINCIPLE FOR USE IN THE PREVENTION AND / OR TREATMENT OF SKIN INJURY |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DO2017000238A DOP2017000238A (en) | 2017-10-16 | 2017-10-16 | COMBINATION OF AT LEAST ONE PROTEASE INHIBITOR AND AT LEAST AN ACTIVE PRINCIPLE FOR USE IN THE PREVENTION AND / OR TREATMENT OF SKIN INJURY |
Publications (1)
Publication Number | Publication Date |
---|---|
DOP2017000238A true DOP2017000238A (en) | 2018-04-30 |
Family
ID=62239787
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DO2017000238A DOP2017000238A (en) | 2017-10-16 | 2017-10-16 | COMBINATION OF AT LEAST ONE PROTEASE INHIBITOR AND AT LEAST AN ACTIVE PRINCIPLE FOR USE IN THE PREVENTION AND / OR TREATMENT OF SKIN INJURY |
Country Status (1)
Country | Link |
---|---|
DO (1) | DOP2017000238A (en) |
-
2017
- 2017-10-16 DO DO2017000238A patent/DOP2017000238A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2573524T3 (en) | New anti-redness active ingredient and cosmetic compositions that comprise it | |
CL2020000220A1 (en) | Compositions comprising amino acids for use in the treatment of diseases related to mitochondrial dysfunction. | |
AR097599A1 (en) | A COMPOSITION THAT INCLUDES GUAÇATONGA AND AROEIRA EXTRACT, ITS USE AND A METHOD FOR THE PREVENTION AND / OR TREATMENT OF SIGNS CAUSED BY SKIN AGING | |
CR9816A (en) | SYNERGETIC COMPOSITION AND METHOD OF USE | |
CO2017011778A2 (en) | An inhibitor of csf-1r activity and pharmaceutical compositions comprising it | |
HK1112721A1 (en) | Tissue disruption treatment and composition for use thereof | |
PH12021551070A1 (en) | Pharmaceutical composition comprising histone deacetylase 6 inhibitors | |
BR112014000795A2 (en) | Cosmetic and / or dermatological use of oligosaccharide compounds in the prevention and treatment of stretch marks. | |
CO2017010543A2 (en) | Combination of at least one protease inhibitor and at least one active ingredient for use in the prevention and / or treatment of skin lesions | |
DOP2017000238A (en) | COMBINATION OF AT LEAST ONE PROTEASE INHIBITOR AND AT LEAST AN ACTIVE PRINCIPLE FOR USE IN THE PREVENTION AND / OR TREATMENT OF SKIN INJURY | |
CL2017002630A1 (en) | Combination of at least one protease inhibitor and at least one active ingredient for use in the prevention and / or treatment of skin lesions | |
PH12020551100A1 (en) | Bowel cleansing composition | |
BRPI1002094A2 (en) | USE OF AT LEAST ONE SOLUBLE PEPTIDIC FORM, AND PROCESSES FOR SCREENING ANTI-AGE ASSETS AND CHARACTERIZING THE EFFECTIVENESS OF A TREATMENT | |
AR064214A1 (en) | USE OF EPOTILONES IN THE TREATMENT OF OSTEOPOROSIS AND RELATED DISEASES | |
DK3727414T3 (en) | SALVIA HAENKEI EXTRACT AS AN ACTIVE AGENT IN TISSUE REPETITION AND ARDANCING PROCESSES | |
PH12018000227B1 (en) | A pharmaceutical composition for improving or preventing progression of chronic kidney disease | |
MX2019011951A (en) | Bacterial secretome for use in the treatment of skin lesions. | |
WO2015044317A3 (en) | Staphylococcus haemolyticus inhibitors for preventing and/or treating atopic dermatitis | |
PE20180161A1 (en) | COMBINATION OF AT LEAST ONE PROTEASE INHIBITOR AND AT LEAST ONE ACTIVE PRINCIPLE FOR USE IN THE PREVENTION AND / OR TREATMENT OF SKIN INJURIES | |
PH12016501448A1 (en) | Antifungal composition | |
EP3338792A4 (en) | Corneal damage prevention/treatment composition comprising thymosin beta 4 and citric acid as active ingredients | |
WO2011067608A8 (en) | Treatment of allodynia and hyperalgesia | |
TH1701006167A (en) | Inclusion of at least one protease inhibitor And at least one active ingredient for use in the prevention and / or treatment of skin lesions. | |
MX2020005682A (en) | Extract of helichrysum gymnocephalum for the treatment and/or prevention of inflammatory dermatoses. | |
ECSP12012332A (en) | ASSOCIATION OF INHIBITORS OF XANTINA OXIDASE AND THE INSTATINE AND ITS USE |